Insider sale
DYNE THERAPEUTICS, INC.
$1.77M
77.39K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND II, L.P. plans to sell 77.39K shares of DYNE THERAPEUTICS, INC. valued at approximately $1.77M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/7/2026ACC: 0001628280-26-047532
10% Owner
Since Dec 2022
77.39K
Shares to sell
$1.77M
Approx. market value
77.39K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
12/12/2022
77.39KTotal acquired77.39K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2022 | Private Placement Cash | 77.39K | — |
| Total | 77.39K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
77.39K
Market value
$1.77M
7/7/2026
Total
Units
77.39K
Value
$1.77M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/7/2026 | 77.39K | $1.77M | Nasdaq | Planned |
| Total | 77.39K | $1.77M | ||